Policy Number

7.17

IWK - 7.17 Preparation of Hazardous Cytotoxic Sterile Products in Pharmacy

Description

Preparation of hazardous cytotoxic sterile products administered to patients in the Health Centre shall be done by the pharmacy department. Specific procedures shall be used to ensure sterility and stability of the drug product, and to minimize the risk of occupational exposure to personnel and reduce the risk of environmental contamination. Hazardous cytotoxic sterile products will be dispensed in appropriate containers that are accurately labelled and appropriate for administration to patients.